Febantel + Praziquantel + Pyrantel Pamoate

Verify with FDA CVM →

5,093 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
5,093
Total Reports
103
Deaths Reported
200.0%
Death Rate

Active Ingredients

FebantelPraziquantelPyrantel Pamoate

Administration Routes

OralUnknownTopicalOther

Species Affected

Dog 4,774
Unknown 279
Cat 32
Cockatiel 4
Human 2
Crustacea 1
Other Birds 1

Most Affected Breeds

Retriever - Labrador 460
Dog (unknown) 330
Unknown 286
Crossbred Canine/dog 280
Chihuahua 274
Retriever - Golden 202
Shih Tzu 197
Pit Bull 186
Shepherd Dog - German 183
Terrier - Yorkshire 183

Most Reported Reactions

Vomiting 1,880
Emesis 605
Emesis (multiple) 566
Diarrhoea 493
Lethargy (see also Central nervous system depression in 'Neurological') 402
Lack of efficacy (endoparasite) - tapeworm 295
Overdose 256
Underdose 228
Anorexia 225
Lack of efficacy (endoparasite) - hookworm 211
Hyperactivity 202
Behavioural disorder NOS 183

Outcome Breakdown

Recovered/Normal
2,654 (55.1%)
Outcome Unknown
1,816 (37.7%)
Ongoing
242 (5.0%)
Died
82 (1.7%)
Euthanized
21 (0.4%)
Recovered with Sequela
3 (0.1%)

Data Summary

Metric Value
Total adverse event reports 5,093
Reports involving death 103
Case-fatality rate (reported events) 200.0%
Distinct species in reports 7
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Febantel + Praziquantel + Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 5,093 adverse event reports referencing Febantel + Praziquantel + Pyrantel Pamoate, including 103 reports in which the animal died — a 200.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Febantel, Praziquantel, Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Topical, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Febantel + Praziquantel + Pyrantel Pamoate reports are Dog (4,774 reports), Unknown (279 reports), Cat (32 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (460), Dog (unknown) (330), Unknown (286) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Febantel + Praziquantel + Pyrantel Pamoate are Vomiting (1,880), Emesis (605), Emesis (multiple) (566), Diarrhoea (493). Of the 4,818 reports with a coded outcome, Recovered/Normal is the leading category at 55.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Febantel + Praziquantel + Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial